About 18,578 results

ALLMedicine™ Diabetic Retinopathy Center

Research & Reviews  6,049 results

Global Prevalence of Diabetic Retinopathy in Pediatric Type 2 Diabetes: A Systematic Re...
JAMA Network Open; Cioana M, Deng J et. al.

Mar 18th, 2023 - Type 2 diabetes (T2D) is increasing globally. Diabetic retinopathy (DR) is a leading cause of blindness in adults with T2D; however, the global burden of DR in pediatric T2D is unknown. This knowledge can inform retinopathy screening and treatment...

Identifying the mechanism of missingness for unspecified diabetic retinopathy disease s...
Journal of the American Medical Informatics Association :... Hatfield M, Nguyen TH et. al.

Mar 18th, 2023 - Observational studies of diabetic retinopathy (DR) using electronic health record data often determine disease severity using International Classification of Disease (ICD) codes. We investigated the mechanism of missingness for DR severity based o...

Frequency of coexistent eye diseases and cognitive impairment or dementia: a systematic...
Eye (London, England); Xu Y, Phu J et. al.

Mar 17th, 2023 - We aim to quantify the co-existence of age-related macular degeneration (AMD), glaucoma, or diabetic retinopathy (DR) and cognitive impairment or dementia. MEDLINE, EMBASE, PsycINFO and CINAHL were searched (to June 2020). Observational studies re...

The average 30-minute post-prandial C-peptide predicted diabetic retinopathy progress: ...
BMC Endocrine Disorders; Pan T, Gao J et. al.

Mar 17th, 2023 - The conclusion between Connecting peptide (C-peptide) and diabetic chronic complication was controversial. The purpose of this study is to explore the possible association between average C-peptide with diabetic retinopathy (DR) progression in Chi...

Macular oedema exacerbation following photocoagulation in a patient with proliferative ...
Clinical & Experimental Optometry; Durmaz Engin C, Saatci AO

Mar 16th, 2023 - Macular oedema exacerbation following photocoagulation in a patient with proliferative diabetic retinopathy.|2023|Durmaz Engin C,Saatci AO,|

see more →

Guidelines  6 results

Diabetic Retinopathy and Maculopathy.
Experimental and Clinical Endocrinology & Diabetes : Offi... Hammes HP, Lemmen KD et. al.

Dec 19th, 2020 - Diabetic Retinopathy and Maculopathy.|2020|Hammes HP,Lemmen KD,Bertram B,|complications,diagnosis,epidemiology,therapy,complications,diagnosis,epidemiology,therapy,diagnosis,epidemiology,therapy,standards,methods,standards,epidemiology,diagnosis,e...

Diabetic Retinopathy Preferred Practice Pattern®.
Ophthalmology Flaxel CJ, Adelman RA et. al.

Nov 24th, 2019 - Diabetic Retinopathy Preferred Practice Pattern®.|2019|Flaxel CJ,Adelman RA,Bailey ST,Fawzi A,Lim JI,|standards,diagnosis,epidemiology,therapy,organization & administration,standards,

Excerpt from the Canadian Ophthalmological Society evidence-based clinical practice gui...
Canadian Journal of Ophthalmology. Journal Canadien D'oph... Hooper P, Boucher MC et. al.

Oct 28th, 2017 - Excerpt from the Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of diabetic retinopathy.|2017|Hooper P,Boucher MC,Cruess A,Dawson KG,Delpero W,|epidemiology,epidemiology,diagnosis,epidemiology,ther...

Diabetic retinopathy and maculopathy.
Experimental and Clinical Endocrinology & Diabetes : Offi... Hammes HP, Lemmen KD et. al.

Jul 12th, 2014 - Diabetic retinopathy and maculopathy.|2014|Hammes HP,Lemmen KD,Bertram B, ,|diagnosis,epidemiology,therapy,complications,epidemiology,complications,epidemiology,diagnosis,epidemiology,etiology,therapy,standards,standards,diagnosis,epidemiology,eti...

Management paradigms for diabetic macular edema.
American Journal of Ophthalmology; Mitchell P, Wong TY et. al.

Nov 26th, 2013 - To provide evidence-based recommendations for diabetic macular edema (DME) management based on updated information from publications on DME treatment modalities. Perspective. A literature search for "diabetic macular edema" or "diabetic maculopath...

see more →

Drugs  5 results see all →

Clinicaltrials.gov  797 results

MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema

Mar 15th, 2023 - This is an open label dose-escalation study to evaluate the safety and treatment benefits of MS-553 in treatment-naive diabetic retinopathy patients with central involved macular edema. Fifteen subjects with diabetic macular edema will be enrolled...

Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema

Mar 14th, 2023 - Diabetes mellitus and its complications represent nowadays an important issue in Public Health terms. The WHO expectations indicate that around 2025 the European population with diabetes will reach about 12%, and it has been estimated that the per...

Evaluation of NeoRetina Artificial Intelligence Algorithm for the Screening of Diabetic Retinopathy at the CHUM

Mar 9th, 2023 - More than 880 000 Quebecers (more than 10% of the population) suffer from diabetes, which is the main cause of blindness in diabetic adults under 65 years of age, and around 40% of people with diabetes suffer from diabetic retinopathy (DR). The ea...

National Eye Institute Biorepository for Retinal Diseases

Mar 9th, 2023 - This protocol establishes a clinical database and biospecimen repository for potential use in subsequent research projects approved by the NIH IRB, such as the identification of novel factors relevant to the pathogenesis, progression, and response...

HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia

Mar 7th, 2023 - This is a study in people with a type of diabetic eye disease called diabetic retinopathy with diabetic macular ischemia. People who have had laser treatment for their diabetic retinopathy can participate in the study. The laser treatment is calle...

see more →

News  561 results

Dexcom G7 CGM Covered by Medicare; T1D Off-Label Drug Use; Another Tepezza Lawsuit

Feb 21st, 2023 - Dexcom announced that its G7 continuous glucose monitoring (CGM) system is now available to all Medicare patients with diabetes who meet the eligibility criteria, following the system launch last week. Half of kids ages 5 and under don't eat a dai...

No Visual Acuity Benefit With Early Anti-VEGF for Diabetic Retinopathy

Feb 7th, 2023 - Longer-term follow-up of a randomized trial confirmed that prophylactic anti-VEGF therapy with aflibercept (Eylea) slows progression of diabetic retinopathy but does not improve visual acuity better than delayed treatment. After 4 years, 34% of pa...

Real-Time CGMs Better; Spinal Cord Stimulation OK'd for DPN; Best Time to Exercise

Jan 31st, 2023 - The 24-month ALERTT1 trial found that switching to a real-time continuous glucose monitor from an intermittently scanned one significantly improved glycemic control and hypoglycemia worry score for people with type 1 diabetes. (The Lancet Diabetes...

Risks From Latent Autoimmune Diabetes in Adults Resemble Those for Type 2 Diabetes

Dec 14th, 2022 - Researchers published the study covered in this summary on Preprints with The Lancet as a preprint that has not yet been peer reviewed. Key Takeaways The risks of death and cardiovascular disease (CVD) in people with latent autoimmune diabetes in ...

Treatment Type Doesn't Affect Risk of Retinal Detachment in DR

Dec 7th, 2022 - There is no increased risk of tractional retinal detachment (TRD) associated with anti-VEGF (vascular endothelial growth factor) intravitreal injection only, compared with laser-only therapy, nor with 6 months or longer of loss to follow-up in pat...

see more →

Patient Education  13 results see all →